US FDA approves Novo Nordisk’s Ozempic 2 mg to treat type-II diabetes EP News Bureau Mar 30, 2022 Ozempic demonstrated 2.1 per cent blood sugar reduction and also weight loss in adults with type-II diabetes with new 2 mg dose
